In early December, two political appointees at the Centers for Disease Control and Prevention began an unusual quest: to find a division within the sprawling agency that could process a grant proposal ...
Race Oncology achieves ethics approval for HARNESS-1 Phase 1a/b trial of RC220 with osimertinib in adults with EGFR-mutant non-small cell lung cancer Ethics approval allows lead clinical site Monash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results